The State Key Laboratory of Emerging Infectious Diseases (SKLEID) at the University of Hong Kong (HKU) is a prestigious research facility Established in 2005, it is one of the State Key Laboratories supported by the Ministry of Science and Technology of China. The laboratory aims to understand the fundamental aspects of emerging infectious diseases. By conducting cutting-edge research, SKLEID contributes to global efforts in combating infectious diseases and improving public health.

SKLEID conducts interdisciplinary research, integrating expertise from various fields. The laboratory’s research projects encompass a wide range of infectious diseases, including influenza, coronaviruses, and other emerging viral infections. SKLEID actively collaborates with national and international partners, including research institutions, governments, and organisations. These collaborations led to the development of innovative diagnostic tools, the development of vaccines and antiviral drugs, and public health policies significantly.

Given its expertise in emerging infectious diseases, SKLEID has been at the forefront of research and response efforts during the COVID-19 pandemic and played a crucial role in its study. SKLEID has been actively involved in various aspects of COVID-19 research, including virus characterization, epidemiology, clinical manifestations and the development of diagnostic tools and vaccines. These studies made significant contributions to a better understanding of the disease and aid the development of effective treatment strategies, control, and management of the COVID-19 pandemic.

By understanding the mechanisms of emerging infectious diseases and their interactions with hosts, the laboratory will continue and identify potential sources of future outbreaks and facilitate proactive surveillance and prevention measures. SKLEID will further strengthen its collaborations with national and international partners to facilitate the exchange of knowledge, expertise, and resources, for fighting against emerging infectious diseases. The laboratory strives to contribute to global health security and the prevention of future pandemics.

香港大學新發性傳染病國家重點實驗室（SKLEID）是一個著名的研究機構。該實驗室成立於 2005 年，是中國科技部支持的國家重點實驗室之一。實驗室旨在了解新發性傳染病的基楚情況。通過進行前沿的研究，協助全球抗擊傳染病和改善公共衛生。

SKLEID 進行的跨領域研究，整合各領域的專業知識。實驗室的研究項目涵蓋各種傳染病，包括流感、冠狀病毒和其他新出現的感染。 SKLEID 積極與國內及國際合作夥伴合作，包括各國的研究機構、政府和國際組織。促成診斷工具的開發及創新、疫苗和抗病毒藥物等發展以及公共衛生政策的發展。

基於其在新發性傳染病方面的專業知識，SKLEID在COVID-19大流行期間一直站在研究和應對工作的最前沿，並在相關的研究中發揮了至關重要的作用。 SKLEID 一直積極參與 COVID-19 研究的各個方面，包括病毒特徵、流行病學、臨床表現、診斷工具以及疫苗的開發等。這些研究凡為進一步了解該疾病做出了重要貢獻，並有助於制定有效的治療策略、控制和管理 COVID-19 大流行。

透過了解新發性傳染病的機制及其與宿主的相互作用，實驗室將繼續找出未來傳染病爆發的潛在來源，並促進主動監測和預防措施。 SKLEID 將進一步加強與國家和國際夥伴的合作，促進知識、專業資訊和資源的交流，以防治新興傳染病。實驗室將更努力為全球衛生安全和預防未來傳染病的爆發作出貢獻。